Atlas FDA

Access Hybritech Free PSA Reagents on the Access Immunoassay Systems

FDA premarket approval P970038/S039 · decided 2019-07-31

Approval details

PMA number
P970038
Supplement
S039
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Access Hybritech Free PSA Reagents on the Access Immunoassay Systems
Generic name
Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
Applicant
Beckman Coulter, Inc.
Date received
2019-05-02
Decision date
2019-07-31
Days to decision
90 days
Decision code
APPR
Product code
MTG
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
Approval for a modification to the UniCel Dxl System Software version 5.5.0 to remove a Y-like command that can result in sample sequencing errors for users who are connected to an automation line.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20